Hyperlipidemia and oxidative stress are known risk factors for the development of various diseases such as cancer, heart disease, atherosclerosis, digestive disease, autoimmune disease, and aging \[[@B1]\]. Reactive oxygen species (ROS), which are oxygen-containing compounds produced by general metabolic pathways, are known to induce oxidative damage to proteins, lipids, and DNA \[[@B2][@B3]\]. Yang et al. \[[@B4]\] suggested that appropriate therapy of increasing antioxidant intake in subjects with abnormally elevated lipid levels can attenuate the course of the disease. However, currently available pharmacological agents for metabolic disorders have a number of limitations, such as various adverse side effects and high rates of secondary failure \[[@B5]\]. Hence, biomedical researchers have been interested in discovering new agents including medicinal herbs that are capable of reducing serum lipid levels.

Plant products are generally considered to be less toxic and thus, cause fewer side effects than drugs manufactured by chemical synthesis. The potential therapeutic and preventive benefits of plant-based medications have been the subject of extensive studies, and many natural constituents have been discovered possessing significant antiglycemic, hypolipidemic, and antihypertensive properties \[[@B6][@B7]\].

Ginseng (root of *Panax ginseng* C.A. Meyer, family Araliaceae) is one of the most commonly used health products or natural remedy medicinal herbs in Asian countries \[[@B8]\]. Red ginseng (RG) is produced by steam processing *P. ginseng* to enhance its biological activities \[[@B9]\]. It has been reported that wild ginseng alleviates metabolic disorders \[[@B10]\]. Moreover, it can be further processed into fermented red ginseng (FRG) by treating with edible microorganisms and enzymes that increase the saponin content to maximize its efficacy \[[@B11]\]. Previous reports have shown that FRG reduced blood glucose levels in streptozotocin-induced diabetic rats \[[@B12][@B13]\]. Furthermore, Korean red ginseng fermented using *Monascus purpureus* (FRG) exhibited hepatoprotective, hypolipidemic, and antioxidative activities in rats \[[@B14]\]. Although many studies have examined the properties of ginseng, no research has been conducted to evaluate the protective effects of FRG against liver injury in hyperlipidemic rats. Therefore, this study is performed to investigate the effects and possible action mechanisms of aqueous extract of FRG in the liver of rats with hyperlipidemia.

Materials and Methods
=====================

Preparation of fermented Korean red ginseng
-------------------------------------------

Fermented Korean red ginseng was prepared using the following procedure: 300 g of six-year-old white dried Korean ginseng (*P. ginseng* Meyer) provided by Samkwang Company (Daejeon, Korea) was immersed in 2 L of distilled water, and steamed for 24 h. A further 4 L of distilled water was added, and the ginseng solution was steamed at 90℃ for 48 h to produce red ginseng (RG) extracts. The RG extracts were used to make FRG extracts by the addition of red yeast rice (*M. purpureus*, KCCM12002) and fermentation for 12 h at 40℃. The FRG was stored 20℃ until further use. The voucher specimen was deposited at the veterinary toxicology laboratory of Kyungpook National University.

Animals
-------

Twenty-eight adult male Sprague-Dawley rats (eight weeks of age) were obtained from Koatech Co. (Osan, Korea). All rats were provided free access to standard rodent chow (AIN-76A diet, \# 100000; Dyets Inc., Bethlehem, PA, USA) and filtered tap water, and were housed in an air-controlled room under standard conditions (temperature, 22±2℃; relative humidity, 50±10%; 12 h light/dark cycle) throughout the study. All animal experiments were performed in accordance with the Guidelines for Animal Care and Use of Kyungpook National University.

Experimental design
-------------------

After one week of acclimatization, the rats were randomly divided into four dietary groups (n=7 in each group). Rats in the normal control (NC) group received regular rodent chow, while those in the other three groups were fed with a high-fat diet (45% kcal fat, Research Diets, New Brunswick, NJ) for eight weeks. Group I (NC) and Group II (high-fat diet control; HFC) animals received filtered tap water and served as the normal and hyperlipidemic control group, respectively, whereas Group III (HF-FRGL) and Group IV (HF-FRGH) animals received drinking water containing 0.5 and 1% FRG for eight weeks, respectively. The rats were allowed free access to food and water during the experimental period. Their weight was measured once a week and diet intakes were calculated by subtracting the remainder from the supply. The gained weight during the experimental period was divided by cumulative dietary intake to obtain the food efficiency ratio (FER); the formula for FER is as follows: FER=weight gained (g)/diet intake (g)×100. At the end of the experiments, all rats were anesthetized by ethyl ether after fasting for 12 h. Blood samples were collected via the posterior vena cava and centrifuged at 1,000×g for 15 min at 4℃. After blood sampling, the liver was dissected and rinsed in physiological saline, blotted on filter paper, and weighed. Serum and liver samples were frozen at −80℃, and were used to measure the biochemical parameters.

Measurement of blood biochemical parameters and lipid profiles
--------------------------------------------------------------

Serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), total cholesterol (TC), triglyceride (TG), low-density lipoprotein-cholesterol (LDL-C), and high-density lipoprotein-cholesterol (HDL-C) were measured using commercial kits (Asan Pharmaceutical Co., Seoul, Korea) with an automatic chemistry analyzer (Hitachi 7180; Hitachi, Tokyo, Japan).

Measurement of hepatic malondialdehyde and antioxidant enzymes
--------------------------------------------------------------

Liver samples were perfused with cold normal saline to completely remove all blood cells, cut into small pieces, placed in 0.2M phosphate buffer (pH 7.4), and homogenized to obtain 20% homogenate. The homogenate was centrifuged at 3,000 rpm for 15 min. Malondialdehyde (MDA) levels, an index of lipid peroxidation, were determined by measuring thiobarbituric acid reactive substances (TBARS) according to the modified method of Draper and Hadley \[[@B15]\]. In addition, superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) activities were determined using the OxiSelect™ kit from Cell Biolabs, Inc. (San Diego, CA, USA).

Histological analysis
---------------------

Liver tissues were removed, fixed with 10% neutral formalin duffer, and embedded in paraffin. The paraffin block samples were cut into 5 µm sections and stained with hematoxylin and eosin (H&E) for histological observation using a light microscope (Olympus BX50; Olympus, Tokyo, Japan).

Statistical analysis
--------------------

The results are presented as the mean±standard deviation (SD). Data were analyzed by SAS software (version 9.3; SAS Institute Inc., Cary, NC, USA). Statistically significance differences between the control and FRG-treated groups were analyzed by Student\'s *t*-test and analysis of variance (ANOVA). *P* values \<0.05 were considered statistically significant.

Results
=======

Effects of FRG on body weight gain and FER
------------------------------------------

The body weight gain and FER of rats after eight weeks are presented in [Table 1](#T1){ref-type="table"}. To determine the effect of FRG on diet efficiency, weight gains in animals were monitored weekly. The body weight gain of rats in the HFC group was higher than that in the NC group (*P*\<0.05). However, FRG-treated animals (0.5 and 1.0%) exhibited lower body weight gain compared to the animals in the HFC group. In addition, the observed change in body weight coincided with a decrease in FER.

Effects of FRG on serum ALT and AST levels
------------------------------------------

Changes in serum levels of ALT and AST of each group are presented in [Table 2](#T2){ref-type="table"}. The serum levels of ALT and AST in the HFC group increased significantly compared to those in the NC group. On the other hand, serum ALT and AST levels were significantly lower in the FRG-treated groups than the HFC group. Although serum AST level in the FRGL group tended to be lower than in the HFC group, the differences were not significant.

Effects of FRG on serum lipid profiles
--------------------------------------

[Figure 1](#F1){ref-type="fig"} shows the effects of FRG on the levels of serum TC, TG, LDL-C, and HDL-C in all experimental groups. Serum TC, LDL-C, and TG levels in the HFC group were significantly (*P*\<0.05) higher than the NC group, while the opposite was observed for serum HDL-C level. Treatment of hyperlipidemic rats with FRG resulted in a significant decline in serum levels of TC, LDL-C, and TG, with an increase in serum HDL-C level. Serum TC levels were 57.3 and 54.7% lower in the FRGL and FRGH groups, respectively, compared to those in the HFC group. Furthermore, serum TG level of the FRGH group was 82.4% lower (*P*\<0.05) than that of the HFC group. The TG levels in the FRGL group was also shown to be reduced by 89.4%, but was not statistically significant. Additionally, the serum LDL-C level was 76.6 and 65.0% lower (*P*\<0.05) in the FRGL and FRGH groups, respectively, compared to the HFC group. In contrast, serum HDL-C levels increased significantly by 133.9 and 178.2% (*P*\<0.05) in the FRGL and FRGH groups, respectively, compared to those in the HFC group.

Effects of FRG on hepatic lipid peroxidation profile
----------------------------------------------------

[Figure 2](#F2){ref-type="fig"} shows the effects of FRG on lipid peroxide levels in hepatic tissue. The amount of MDA in the HFC group was 0.98±0.09 nmole/mg protein, which was 169.0% higher than that in the NC group. Treatment with FRGL and FRGH significantly reduced MDA levels compared to the HFC group by 14.3 and 27.6%, respectively.

Effects of FRG on hepatic antioxidant enzyme activities
-------------------------------------------------------

The antioxidant activities of hepatic SOD, CAT, and GSH-Px are shown in [Table 3](#T3){ref-type="table"}. The activities of SOD, CAT, and GSH-Px in the HFC group decreased significantly (*P*\<0.05) compared to the NC group by 57.1, 59.5, and 67.6%, respectively. However, FRGL treatment led to a significant increase (*P*\<0.05) in the activities of SOD (64.3%) and CAT (86.3%) compared to the HFC group. The FRGL treatment also increased the activity of GSH-Px relative to that of the HFC group, but not significantly. On the other hand, activities of hepatic SOD, CAT, and GSH-Px increased significantly (*P*\<0.05) upon FRGH treatment compared to those of the HFC group.

Histopathologic analysis of liver sections
------------------------------------------

Liver sections of rats in the NC group showed normal distinct hepatic cells, sinusoidal spaces, and a central vein. However, liver sections of the HFC group showed presence of extensive lipid-droplet vacuoles in hepatocytes, disarrangement of hepatic cells, necrotic changes of central lobes, and hepatic lobule damage. In the FRG-treated groups, fatty denaturalization of hepatocytes decreased noticeably and the disordered hepatocytes were restored to their original arrangement (as seen in the NC group), in a dose-dependent manner ([Figure 3](#F3){ref-type="fig"}).

Discussion
==========

The various preparation methods of Korean ginseng can alter the formation and concentration of saponins in the ginseng extract \[[@B11][@B16]\]. These extracts are known to improve blood flow, relieve fatigue, and attenuate oxidative stress in the body \[[@B8][@B9][@B17]\]. Furthermore, Lee et al. \[[@B18]\] reported that Korean white ginseng extracts regulated lipogenesis-related gene expressions in white adipose tissues, inhibited intestinal fat absorption, and reduced body weight.

Hyperlipidemia is characterized by increased TC, TG, and LDL-C levels and by decreased HDL-C levels, and is considered to be one of the major risk factors for liver cirrhosis, hepatocellular carcinoma, and liver failure \[[@B19]\]. Although statins, also known as 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, are effective therapies for reducing serum LDL-C levels, they also induce adverse side effects including muscle myopathy and derangements in hepatic function \[[@B20]\].

In this study, FRG (0.5 and 1.0%) treatment reduced body weight gain of rats compared to the animals in the HFC group. Moreover, FER in the FRG-treated groups were significantly lower than in the HFC group. These results suggest that FRG treatment can prevent high-fat diet-induced weight gain by decreasing food efficiency. The enzymes ALT and AST are markers of hepatopathy in the blood. The high level of serum ALT and AST is interpreted as an indication of hepatocellular damage. In the present study, levels of serum ALT and AST in the HFC group were higher than in the NC group. However, FRG treatment resulted in a notable decrease in ALT and AST levels compared with those in the HFC group, indicating that FRG exhibits hepatoprotective effects.

The hallmark of dyslipidemia is hypertriglyceridemia in combination with high LDL-C and low HDL-C levels \[[@B21]\]. In this study, the HFC group showed a significant increase in TC, TG, and LDL-C levels, as well as decrease in HDL-C level, compared to the NC group. On the other hand, the FRG-treated groups exhibited an opposing trend with regard to the levels of TC, TG, LDL-C, and HDL-C compared with the HFC group, in a dose-dependent manner ([Figure 1](#F1){ref-type="fig"}). It was reported that ginseng \[[@B22]\] and red ginseng \[[@B23]\] extracts improved lipid metabolism. Similarly, the present results indicate that FRG contributed to the reduction of lipid accumulation in hyperlipidemic rats.

The activities of SOD, CAT, and GSH-Px in the FRG-treated groups were significantly higher than those in the HFC group. This could result from the increased utilization of these enzymes for scavenging the overproduced oxygen free radicals induced by the high-fat diet. Superoxide dismutase is an important enzyme in the body produced in the early stage of free radical generation, and functions to accelerate the dismutation of superoxide anion radicals into either hydrogen peroxide or O~2~. The enzymes CAT and GSH-Px on the other hand, remove the hydrogen peroxide produced by SOD to protect the body from peroxidative damage \[[@B24]\]. Deficiency of GSH-Px is often associated with accelerated aging and degenerative diseases \[[@B25]\]. Hence, SOD, CAT, and GSH-Px collectively protect cell membranes and intracellular materials from ROS attack in the body. It is expected that FRG treatment may increase the activity of SOD, CAT, and GSH-Px to eliminate harmful ROS. Previously, Kim and Park \[[@B22]\] reported that the activity of SOD and CAT increased after administration of ginseng extract for eight weeks in humans. These results indicate that FRG can improve antioxidant enzyme activities in hyperlipidemic animals.

To determine whether FRG exhibits anti-lipid peroxidation activities in hyperlipidemic rats, the level of hepatic MDA was measured. As one of the final products of polyunsaturated fatty acid peroxidation, MDA is a common marker of oxidative stress \[[@B15]\]. As shown in [Figure 2](#F2){ref-type="fig"}, the level of TBARS in the HFC group was significantly elevated compared to that in the NC group, and FRG treatment notably suppressed the peroxidation process. High-fat diets have been shown to increase free radical production *in vivo*, which results in elevated lipid peroxide levels \[[@B15]\]. In this study, FRG treatment induced increase in SOD, CAT, and GSH-Px levels, as well as decrease in MDA levels in the hyperlipidemia rat model, suggesting that its protective role in the liver of hyperlipidemic rats is associated with enhancing the antioxidant ability of these rats. On the whole, the effects of FRG were dose-dependent, but there were no statistical significance between FRGL and FRGH results.

Histopathological analysis showed that the livers of rats fed an HF diet developed signs of hepatosteatosis ([Figure 3](#F3){ref-type="fig"}), and indicated that FRG treatment may reduce hepatocellular damage and play a protecting role against liver damage caused by high-fat diet. Hence, administration of FRG could reduce hepatic lipid deposition to prevent the occurrence of fatty liver. Generally, hypertrophy and fatty change of hepatocytes induced by high-fat diet are accompanied by increased AST and ALT activities \[[@B26][@B27]\]. The present results showed that FRG ameliorated hepatic steatosis by regulating lipid metabolism, and exhibited protective effects on hepatic structure. Recently, Kim et al \[[@B28]\] reported that the RG effect alleviating obesity-mediated metabolic disorders was enhanced by red *koji* fermentation.

In conclusion, the present findings showed that FRG could suppress body weight gain, reduce the amount of body fat, improve blood lipid profile, enhance the antioxidant status, and inhibit lipid peroxidation in rats fed with high-fat diet, and that FRG may therefore, act as a potent hypolipidemic and antioxidant functional food.
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![Alterations in serum lipid profiles in rats treated with FRG. TG, triglyceride; TC, total cholesterol; LDL-C, low density lipoproteincholesterol; HDL-C, high density lipoprotein-cholesterol. Data shown are mean±S.E.M. (n=5). ^\*^Mean values were significantly different from NC group: *P*\<0.05. ^\#^Mean values were significantly different from HFC group: *P*\<0.05.](lar-32-217-g001){#F1}

![Alterations in hepatic malondialdehyde (MDA) level in rats treated with FRG. Data shown are mean±S.E.M. (n=5). ^\*^Mean values were significantly different from NC group: *P*\<0.05. ^\#^Mean values were significantly different from HFC group: *P*\<0.05.](lar-32-217-g002){#F2}

![Histopathological examination of the rat liver tissues in hyperlipidemic rats treated with fermented red ginseng (FRG). Tissues were stained with hematoxylin and eosin. The liver section was stained using hematoxylin and eosin at 200×. NC, normal control; HFC, high fat diet control, HF+FRGL: high fat diet+FRG 0.5%, HF+FRGH: high fat diet+FRG 1.0%](lar-32-217-g003){#F3}

###### The body weight gain and food efficiency ratio in rats treated with FRG

![](lar-32-217-i001)

  Group     Body weight gain (g/8 weeks)   Food efficiency ratio (%)
  --------- ------------------------------ ---------------------------
  NC        190.5±17.3^\#^                 0,21±0.02^\#^
  HFC       231.6±16.7^\*^                 0.28±0.02^\*^
  HF+FRGL   201.2±17.1^\#^                 0.24±0.02^\#^
  HF+FRGH   194.1±16.2^\#^                 0.23±0.02^\#^

All values are mean SD of 7 rats for each group.

NC: normal control. HFC: high fat diet control, HF+FRGL: high fat diet+FRG 0.5%, HF+FRGH: high fat diet+FRG 1.0%

Food efficiency ratio; body weight gain/food intake.

^\*^Mean values were significantly different from NC group: *P*\<0.05.

^\#^Mean values were significantly different from HFC group: *P*\<0.05.

###### The levels of serum ALT and AST in rats treated with FRG

![](lar-32-217-i002)

  Group     ALT (U/L)      AST (U/L)
  --------- -------------- ----------------
  NC        34.8±4.3^\#^   95.2±8.9^\#^
  HFC       61.3±7.5\*     169.7±15.1^\*^
  HF+FRGL   45.1±5.1^\#^   141.5±13.3^\*^
  HF+FRGH   41.2±3.9^\#^   120.9±11.6^\#^

All values are mean SD of 7 rats for each group.

NC: normal control. HFC: high fat diet control, HF+FRGL: high fat diet+FRG 0.5%, HF+FRGH: high fat diet+FRG 1.0%

ALT: alanine aminotransferase, AST: aspartate aminotransferase

^\*^Mean values were significantly different from NC group: *P*\<0.05.

^\#^Mean values were significantly different from HFC group: *P*\<0.05.

###### The hepatic antioxidant enzyme activities in hyperlipidemic rats treated with FRG

![](lar-32-217-i003)

  Group     SOD (U/mg protein)   CAT (U/mg protein)   GSH-Px (U)
  --------- -------------------- -------------------- ----------------
  NC        124.7±14.3^\#^       39.5±4.2^\#^         118.5±10.2^\#^
  HFC       71.2±7.0^\*^         23.5±2.4^\*^         80.1±8.5^\*^
  HF+FRGL   80.2±7.8^\#^         34.1±3.5^\#^         89.6±9.1^\*^
  HF+FRGH   89.4±8.2^\#^         36.2±3.8^\#^         103.4±9.8^\#^

All values are mean SD of 7 rats for each group.

NC: normal control. HFC: high fat diet control, HF+FRGL: high fat diet+FRG 0.5%, HF+FRGH: high fat diet+FRG 1.0%

ALT: alanine aminotransferase, AST: aspartate aminotransferase, GLU: glucose

^\*^Mean values were significantly different from NC group: *P*\<0.05.

^\#^Mean values were significantly different from HFC group: *P*\<0.05.
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